Myovant, Pfizer debut first branded campaign for prostate cancer med Orgovyx
Myovant and Pfizer are pointing up the fact that prostate cancer treatment Orgovyx is a pill in the first direct-to-consumer campaign for the brand.
The advertising pulls the middle syllable from the brand name, encouraging people to “GO with the facts” and talk to a doctor about the oral androgen deprivation therapy (ADT). Real patients and caregivers are featured on the brand website, which also includes a link to an Orgovyx resource called “The MANual.” That platform, launched last year, is meant to help patients when starting on the drug and includes a tracking app, educational material and prostate cancer support community connections.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 157,800+ biopharma pros reading Endpoints daily — and it's free.